Peter Staib
Clinic I for Internal Medicine
University of Cologne
Germany
Name/email consistency: high
- Plasma levels of tumor M2-pyruvate kinase should not be used as a tumor marker for hematological malignancies and solid tumors. Staib, P., Hoffmann, M., Schinköthe, T. Clin. Chem. Lab. Med. (2006)
- Prediction of individual response to chemotherapy in patients with acute myeloid leukaemia using the chemosensitivity index Ci. Staib, P., Staltmeier, E., Neurohr, K., Cornely, O., Reiser, M., Schinköthe, T. Br. J. Haematol. (2005)
- Determination of caspase-3 activation fails to predict chemosensitivity in primary acute myeloid leukemia blasts. Staib, P., Tiehen, J., Strunk, T., Schinköthe, T. BMC. Cancer (2005)
- Cytosine arabinoside, etoposide and aclarubicin (AVA) for the treatment of acute myeloid leukemia (AML) in elderly patients. Staib, P., Lathan, B., Knöppel-Schwark, S., Tesch, H., Voliotis, D., Steinmetz, H.T., Schwonzen, M., Wickramanayake, P.D., Diehl, V. Ann. Oncol. (1998)